{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:40:49Z","timestamp":1792518049737,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Project of Inner Mongolia Medical University","award":["grant numbers: YKD2023LH015"],"award-info":[{"award-number":["grant numbers: YKD2023LH015"]}]},{"name":"Joint Project of Inner Mongolia Medical University","award":["grant numbers: YKD2023LH015"],"award-info":[{"award-number":["grant numbers: YKD2023LH015"]}]},{"name":"Joint Project of Inner Mongolia Medical University","award":["grant numbers: YKD2023LH015"],"award-info":[{"award-number":["grant numbers: YKD2023LH015"]}]},{"name":"Joint Project of Inner Mongolia Medical University","award":["grant numbers: YKD2023LH015"],"award-info":[{"award-number":["grant numbers: YKD2023LH015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03453-w","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:45:35Z","timestamp":1792471535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL1RAP promotes EMT and metastatic phenotypes in papillary thyroid carcinoma and is associated with PI3K\/AKT signaling activation"],"prefix":"10.1007","volume":"43","author":[{"given":"Yongkui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"3453_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/PAP.0000000000000198","volume":"25","author":"Z Guo","year":"2018","unstructured":"Guo Z, Ge M, Chu YH, Asioli S, Lloyd RV. Recent advances in the classification of low-grade papillary-like thyroid neoplasms and aggressive papillary thyroid carcinomas: evolution of diagnostic criteria. Adv Anat Pathol. 2018;25:263\u201372.","journal-title":"Adv Anat Pathol"},{"key":"3453_CR2","first-page":"180","volume":"2","author":"Y Vayisoglu","year":"2013","unstructured":"Vayisoglu Y, Ozcan C. Involvement of level IIb lymph node metastasis and dissection in thyroid cancer. Gland Surg. 2013;2:180\u20135.","journal-title":"Gland Surg"},{"key":"3453_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"Ringel MD, Sosa JA, Baloch Z, Bischoff L, Bloom G, Brent GA, et al. 2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer. Thyroid. 2025;35:841\u2013985.","journal-title":"Thyroid"},{"key":"3453_CR4","first-page":"402","volume":"30","author":"M Guo","year":"2022","unstructured":"Guo M, Wang L, Huang Y, et al. Identification of core genes associated with lymph node metastasis and distant metastasis in papillary thyroid carcinoma based on weighted gene co-expression network analysis. Mod Oncol. 2022;30:402\u20137. (In Chinese).","journal-title":"Mod Oncol"},{"key":"3453_CR5","doi-asserted-by":"publisher","first-page":"1440722","DOI":"10.3389\/fendo.2024.1440722","volume":"15","author":"AM Sigarteu Chindris","year":"2024","unstructured":"Sigarteu Chindris AM, Rivera M, Ma Y, Nair A, Liu Y, Wang X, Necela BM, et al. BRAFV600E\/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression. Front Endocrinol. 2024;15:1440722.","journal-title":"Front Endocrinol"},{"key":"3453_CR6","doi-asserted-by":"publisher","first-page":"113532","DOI":"10.1016\/j.intimp.2024.113532","volume":"143","author":"B Li","year":"2024","unstructured":"Li B, Cai Z, Zhang Y, Chen R, Tang S, Kong F, Li W, Ding L. Biomarkers associated with papillary thyroid carcinoma and Hashimoto\u2019s thyroiditis: bioinformatic analysis and experimental validation. Int Immunopharmacol. 2024;143:113532.","journal-title":"Int Immunopharmacol"},{"key":"3453_CR7","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.21037\/tcr-2024-2568","volume":"14","author":"L Xin","year":"2025","unstructured":"Xin L, Li C, Ni H, Fu G, Qin Q, Zhang L. Clinical value of SPP1 overexpression in patients with papillary thyroid carcinoma. Transl Cancer Res. 2025;14:4100\u201314.","journal-title":"Transl Cancer Res"},{"key":"3453_CR8","doi-asserted-by":"publisher","first-page":"e44540","DOI":"10.1097\/MD.0000000000044540","volume":"104","author":"LTT Nhung","year":"2025","unstructured":"Nhung LTT, Hoan NX, Giang DP, Dung DT, Phuong NT, Hanh NTM, Khanh LV, Hang NT. Prognostic significance of BRAF V600E and TERT promoter mutations in radioiodine resistance and recurrence of differentiated thyroid cancer. Med (Baltim). 2025;104:e44540.","journal-title":"Med (Baltim)"},{"key":"3453_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40364-025-00769-z","volume":"13","author":"A M\u00e9tois","year":"2025","unstructured":"M\u00e9tois A, Bordeleau M-E, Theret L, Hajmirza A, Moujaber O, Spinella J-F, Chagraoui J, Mayotte N, Boivin I, Audemard \u00c9, et al. IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia. Biomark Res. 2025;13:61.","journal-title":"Biomark Res"},{"key":"3453_CR10","doi-asserted-by":"publisher","first-page":"153303382199528","DOI":"10.1177\/1533033821995282","volume":"20","author":"Q Lv","year":"2021","unstructured":"Lv Q, Xia Q, Li A, Wang Z. The potential role of IL1RAP on tumor microenvironment-related inflammatory factors in stomach adenocarcinoma. Technol Cancer Res Treat. 2021;20:1533033821995282.","journal-title":"Technol Cancer Res Treat"},{"key":"3453_CR11","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/ard-2023-225158","volume":"83","author":"C Gronberg","year":"2024","unstructured":"Gronberg C, Rattik S, Tran-Manh C, et al. Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis. Ann Rheum Dis. 2024;83:1156\u201368.","journal-title":"Ann Rheum Dis"},{"key":"3453_CR12","doi-asserted-by":"publisher","first-page":"104200","DOI":"10.1016\/j.critrevonc.2023.104200","volume":"193","author":"A Zarezadeh Mehrabadi","year":"2024","unstructured":"Zarezadeh Mehrabadi A, Shahba F, Khorramdelazad H, Aghamohammadi N, Karimi M, Bagherzadeh K, Khoshmirsafa M, Massoumi R, Falak R. Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies. Crit Rev Oncol Hematol. 2024;193:104200. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104200.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3453_CR13","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1182\/blood-2012-09-458935","volume":"121","author":"M Askmyr","year":"2013","unstructured":"Askmyr M, Agerstam H, Hansen N, et al. Selective killing of candidate AML stem cells by antibody targeting of IL1RAP. Blood. 2013;121:3709\u201313.","journal-title":"Blood"},{"key":"3453_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1158\/0008-5472.CAN-18-1078","volume":"79","author":"W Warda","year":"2019","unstructured":"Warda W, Larosa F, Neto Da Rocha M, et al. CML hematopoietic stem cells expressing IL1RAP can be targeted by chimeric antigen receptor-engineered T cells. Cancer Res. 2019;79:663\u201375.","journal-title":"Cancer Res"},{"key":"3453_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxics12010073","volume":"12","author":"EJ Jung","year":"2024","unstructured":"Jung EJ, Jo JH, Uwamahoro C, Chae JB, Park JS, et al. Ritonavir has reproductive toxicity depending on disrupting PI3K\/PDK1\/AKT signaling pathway. Toxics. 2024;12:1.","journal-title":"Toxics"},{"key":"3453_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s10735-026-10747-w","volume":"57","author":"Y Deng","year":"2026","unstructured":"Deng Y, Lei Y, Ou Y, Li J, Hu X, Wen L, Hou K. miR-34c-3p promotes osteogenic differentiation of BMSCs by inhibiting DCBLD2 activation of the PI3K\/AKT signaling pathway. J Mol Histol. 2026;57:86.","journal-title":"J Mol Histol"},{"key":"3453_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s12013-024-01299-5","volume":"82","author":"H Du","year":"2024","unstructured":"Du H, You L, Wu A, Wang F, Yu J, Chen C. Resolvin D1 inhibits IL-6-induced epithelial-mesenchymal transition of colorectal cancer cells by targeting IL-6\/STAT3 signaling. Cell Biochem Biophys. 2024;82:1453\u201361.","journal-title":"Cell Biochem Biophys"},{"key":"3453_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","volume":"698","author":"S Noorolyai","year":"2019","unstructured":"Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. The relation between PI3K\/AKT signalling pathway and cancer. Gene. 2019;698:120\u20138.","journal-title":"Gene"},{"key":"3453_CR19","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s11064-022-03811-w","volume":"48","author":"J Zhou","year":"2023","unstructured":"Zhou J, Xiang W, Zhang K, Zhao Q, Xu Z, Li Z. IL1RAP knockdown in LPS-stimulated normal human astrocytes suppresses LPS-induced reactive astrogliosis and promotes neuronal cell proliferation. Neurochem Res. 2023;48:1468\u201379.","journal-title":"Neurochem Res"},{"key":"3453_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.21037\/atm-22-2810","volume":"10","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang N, Fu X, et al. Bioinformatic analysis of cancer-associated fibroblast related gene signature as a predictive model in clinical outcomes and immune characteristics of gastric cancer. Ann Transl Med. 2022;10:698.","journal-title":"Ann Transl Med"},{"key":"3453_CR21","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.5650\/jos.ess21399","volume":"71","author":"J Sun","year":"2022","unstructured":"Sun J, Meng M. Chemoprotective effect of scutellarin against gastric cancer in rats: an in vitro and in vivo study. J Oleo Sci. 2022;71:1003\u201312.","journal-title":"J Oleo Sci"},{"key":"3453_CR22","doi-asserted-by":"publisher","first-page":"108636","DOI":"10.1016\/j.compbiomed.2024.108636","volume":"177","author":"Y Sun","year":"2024","unstructured":"Sun Y, Zhang Y, Gan J, et al. Comprehensive quantitative radiogenomic evaluation reveals novel radiomic subtypes with distinct immune pattern in glioma. Comput Biol Med. 2024;177:108636.","journal-title":"Comput Biol Med"},{"key":"3453_CR23","doi-asserted-by":"publisher","first-page":"117077","DOI":"10.1016\/j.taap.2024.117077","volume":"491","author":"K Wu","year":"2024","unstructured":"Wu K, Qiu C, Ma Q, Chen F, Lu T. The anti-cancer mechanism of celastrol by targeting JAK2\/STAT3 signaling pathway in gastric and ovarian cancer. Toxicol Appl Pharmacol. 2024;491:117077.","journal-title":"Toxicol Appl Pharmacol"},{"key":"3453_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000543409","volume":"48","author":"H Huang","year":"2025","unstructured":"Huang H, Ma J, Cui H, Liang T, Ma Q. Identification of biomarkers for cervical cancer radiotherapy sensitivity and survival prognosis. Oncol Res Treat. 2025;48:197\u2013211.","journal-title":"Oncol Res Treat"},{"key":"3453_CR25","doi-asserted-by":"publisher","unstructured":"Wang Y, Zhang Y, Li Y, Ma H, Zhao J, Ismtula D, Guo C. The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification. Front. Immunol. 2026, 17, 1770711. https:\/\/doi.org\/10.3389\/fimmu.2026.1770711. PMID: 41884849.","DOI":"10.3389\/fimmu.2026.1770711"},{"key":"3453_CR26","doi-asserted-by":"publisher","unstructured":"Gou Y, Li Y, Wang Y, Ma H, Li H, Geni R, Ismtula D, Guo C. Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker. Breast Cancer: Targets and Therapy 2025, 17, 1439\u20131461. https:\/\/doi.org\/10.2147\/BCTT.S553681. PMID: 41497890.","DOI":"10.2147\/BCTT.S553681"},{"key":"3453_CR27","doi-asserted-by":"publisher","unstructured":"Wang J, Wang Y, Ma H, Li Y, Hou J, Li J, Ismtula D, Guo C. CLIC6\u2019s role in cancer: from broad analysis to breast cancer validation. Front. Oncol. 2025, 15, 1667589. https:\/\/doi.org\/10.3389\/fonc.2025.1667589. PMID: 41142627.","DOI":"10.3389\/fonc.2025.1667589"},{"key":"3453_CR28","doi-asserted-by":"publisher","unstructured":"Elihamu D, Li Y, Wang Y, Cui H, Xing Y, Peng H, Ismtula D, Guo C. CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation. Front. Oncol. 2025, 15, 1670526. https:\/\/doi.org\/10.3389\/fonc.2025.1670526. PMID: 41122645.","DOI":"10.3389\/fonc.2025.1670526"},{"key":"3453_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-026-08649-6","volume":"17","author":"W Song","year":"2026","unstructured":"Song W, Liu Z, Shi C, Wang G, He L, Chen Z, Li Y, Yu Y. RAN-S100A10-EGFR axis facilitates papillary thyroid cancer metastasis by PI3K\/AKT signaling. Cell Death Dis. 2026;17:1.","journal-title":"Cell Death Dis"},{"key":"3453_CR30","doi-asserted-by":"publisher","first-page":"124072","DOI":"10.1016\/j.envres.2026.124072","volume":"297","author":"Y Yu","year":"2026","unstructured":"Yu Y, Wang Y, Su X, Cai Z, Wang Q, Wang C, Zhao Y, Zhang T. PFOS exposure at environmentally relevant concentrations promotes papillary thyroid carcinoma progression through PI3K\/AKT\/mTOR-mediated epithelial-mesenchymal transition. Environ Res. 2026;297:124072.","journal-title":"Environ Res"},{"key":"3453_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-026-04242-5","volume":"24","author":"L Jia","year":"2026","unstructured":"Jia L, Han Y, Chen Z, Wang Y, Zhao K, He X. Milk fat globule-EGF factor 8 enhances the proliferation and migration of thyroid carcinoma cells through epithelial-mesenchymal transition and PI3K\/AKT signaling pathway. World J Surg Oncol. 2026;24:1.","journal-title":"World J Surg Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03453-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03453-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03453-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:01:39Z","timestamp":1792515699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03453-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3453"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03453-w","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used publicly available datasets containing de-identified human tumor data. No personal identifying information was accessed or disclosed. The experimental component was approved by the Ethics Committee of Chifeng Hospital. The authors used language-editing assistance to improve readability and subsequently reviewed and edited all content; the authors take full responsibility for the final manuscript.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"344"}}